Articles and Insights About Wearables for Clinical Trials

Oncology

Webinar: Holistic Measures of Physical Functioning in Cancer

 VivoSense Team

Suvekshya Aryal, a VivoSense Research scientist, moderated a live discussion about the holistic measurement of physical function in cancer and opportunities for digital health technologies to provide value.

Read More

Measuring What Is Meaningful in Cancer Cachexia Clinical Trials

 VivoSense Team

VivoSense recently published an American Society of Clinical Oncology's JCO Clinical Cancer Informatics review article, Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior.

Read More

Capturing Real-World Physical Behavior in Cancer Survivors

 Shelby Bachman, PhD

VivoSense Research Scientist Shelby Bachman, PhD, presented the poster, Real-world physical behavior is associated with aerobic fitness, but not patient-reported outcomes, in cancer survivors, at the October 22, 2023, Banff 9th Annual PROMIS International Conference, a multi-disciplinary forum for learning about the use of patient-reported outcome measures in clinical care and research. Shelby’s poster presentation summarized VivoSense’s recent work examining the clinical utility of real-world digital measures in oncology. Here's a quick snapshot of the poster content.

Read More

Assessing Physical Function with Wearable Sensors in Cancer Survivors

 Shelby Bachman, PhD

Research scientist Shelby Bachman, PhD, spoke at the Roche Digital Biomarkers in Clinical Trials Summit on the prospects for wearable sensors for measuring health-related quality of life in cancer survivors.

Read More

VivoSense Joins CancerX to Advance Digital Innovation in Research

 Ieuan Clay, PhD

On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!

Read More

Oncology Research and Care: Reimagining Digital Innovation

 Kate Lyden, PhD

Oncology research has been slower to adopt digital clinical measures than other therapeutics specialties in healthcare and drug development. Thought leaders are working to reverse this trend and rapidly integrate digital clinical measures in oncology patient care and clinical research.

Read More

VivoSense Awarded NIH/NCI Grant to Aid in Cancer Research

 Dudley Tabakin

VivoSense, Inc. is proud to announce that we have been awarded an NIH/NCI Phase 1 contract to develop software enabling data integration from wearable sensors for cancer patients. The contract will result in the development of the VivoSense Cancer Health Informatics Platform as the leading wearable sensor agnostic cloud platform for cancer research and clinical care.

Read More
 Newer All Articles Older 

Stay Connected

Popular